On the mechanism of action of rFVIIa administered to patients with severe thrombocytopenia and life-threatening haemorrhage. Focus on prothrombin activation - Gerotziafas, GT; Zervas, K; Arzoglou, P (Br J Haematol, 2002)
et al.